📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Bellerophon Therapeutics

1.1 - Company Overview

Bellerophon Therapeutics Logo

Bellerophon Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of innovative products that combine novel drugs and devices for the treatment of cardiopulmonary diseases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Bellerophon Therapeutics

Cardurion Pharmaceuticals Logo

Cardurion Pharmaceuticals

HQ: United States Website
  • Description: Provider of cardiovascular therapeutics and research services, developing a PDE9 inhibitor for HFrEF and HFpEF to enhance existing therapy; a CaMKII inhibitor for CPVT, heart failure, and atrial fibrillation; and conducting clinical trials, plus medicinal chemistry, computational molecular modeling, and genetic engineering support for cardiovascular research.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cardurion Pharmaceuticals company profile →
AUM Cardiovascular Logo

AUM Cardiovascular

HQ: United States Website
  • Description: Provider of medical device manufacturing solutions specializing in the biotechnology, medical, and healthcare fields.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AUM Cardiovascular company profile →
AdvancedCath Logo

AdvancedCath

HQ: United States Website
  • Description: Provider of advanced catheter systems and components, offering design, development and manufacturing services. Delivers high-quality, fast-response, superior solutions and proactive service through a collaborative partnership approach, serving as a fast and flexible development partner.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AdvancedCath company profile →
nContact Logo

nContact

HQ: United States Website
  • Description: Provider of medical devices supporting endoscopic treatments for heart rhythm disorders and arrhythmias, including atrial fibrillation (AF). Offers the Numeris Coagulation System with VisiTrax, integrating suction, perfusion, and RF energy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full nContact company profile →
Advanced Perfusion Diagnostics Logo

Advanced Perfusion Diagnostics

HQ: France Website
  • Description: Provider of innovative patient monitoring systems, developing, manufacturing and marketing solutions that deliver relevant tissue perfusion indicators to clinicians; based in Lyon, France, with the IKORUS monitoring system.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Advanced Perfusion Diagnostics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Bellerophon Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Bellerophon Therapeutics

2.2 - Growth funds investing in similar companies to Bellerophon Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Bellerophon Therapeutics

4.2 - Public trading comparable groups for Bellerophon Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Bellerophon Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Bellerophon Therapeutics

What does Bellerophon Therapeutics do?

Bellerophon Therapeutics is a provider of innovative products that combine novel drugs and devices for the treatment of cardiopulmonary diseases.

Who are Bellerophon Therapeutics's competitors?

Bellerophon Therapeutics's competitors and similar companies include Cardurion Pharmaceuticals, AUM Cardiovascular, AdvancedCath, nContact, and Advanced Perfusion Diagnostics.

Where is Bellerophon Therapeutics headquartered?

Bellerophon Therapeutics is headquartered in United States.

How many employees does Bellerophon Therapeutics have?

Bellerophon Therapeutics has 1,000 employees 🔒.

When was Bellerophon Therapeutics founded?

Bellerophon Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Bellerophon Therapeutics in?

Bellerophon Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Bellerophon Therapeutics

Who are the top strategic acquirers in Bellerophon Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Bellerophon Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Bellerophon Therapeutics?

Top strategic M&A buyers groups and sectors for Bellerophon Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Bellerophon Therapeutics's sector and industry vertical

Which are the top PE firms investing in Bellerophon Therapeutics's sector and industry vertical?

Top PE firms investing in Bellerophon Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Bellerophon Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Bellerophon Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Bellerophon Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Bellerophon Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Bellerophon Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Bellerophon Therapeutics?

The key public trading comparables and valuation benchmarks for Bellerophon Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Bellerophon Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Bellerophon Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Bellerophon Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Bellerophon Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Bellerophon Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Bellerophon Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Bellerophon Therapeutics